Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $5.42 USD
Change Today -0.03 / -0.55%
Volume 85.5K
TRIV On Other Exchanges
As of 8:10 PM 07/2/15 All times are local (Market data is delayed by at least 15 minutes).

trivascular technologies inc (TRIV) Snapshot

Previous Close
Day High
Day Low
52 Week High
07/8/14 - $17.25
52 Week Low
06/30/15 - $5.08
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

Related News

No related news articles were found.

trivascular technologies inc (TRIV) Related Businessweek News

No Related Businessweek News Found

trivascular technologies inc (TRIV) Details

TriVascular Technologies, Inc., a medical device company, develops and commercializes technologies to advance minimally invasive treatment of abdominal aortic aneurysms (AAA). The company offers Ovation System, a stent graft platform for the treatment of AAA through minimally invasive endovascular aortic repair. Its ovation system components include arotic body, iliac limbs, and fill polymer. The company markets and sells its products through direct sales organizations in the United States, Germany, the United Kingdom, the Netherlands, and Canada, as well as through distributors or agents in other markets. TriVascular Technologies, Inc. was incorporated in 2007 and is headquartered in Santa Rosa, California.

307 Employees
Last Reported Date: 03/9/15
Founded in 2007

trivascular technologies inc (TRIV) Top Compensated Officers

Chairman, Chief Executive Officer and Preside...
Total Annual Compensation: $450.0K
Co-Founder and Chief Technology Officer
Total Annual Compensation: $296.3K
Chief Financial Officer and Principal Account...
Total Annual Compensation: $356.2K
Compensation as of Fiscal Year 2014.

trivascular technologies inc (TRIV) Key Developments

TriVascular Technologies, Inc.(NasdaqGS:TRIV) dropped from Russell 2000 Index

TriVascular Technologies, Inc. will be removed from Russell 2000 Index

TriVascular Technologies, Inc.(NasdaqGS:TRIV) dropped from Russell 3000 Index

TriVascular Technologies, Inc. will be removed from Russell 3000 Index.

TriVascular Technologies, Inc. Announces FDA Approval of Ovation iX(TM) Iliac Stent Graft

TriVascular Technologies, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved the Ovation iX Iliac Stent Graft for the Ovation Prime® Abdominal Stent Graft System, together with manufacturing enhancements that will facilitate a broader commercial launch of the product. Building upon the strength of the Ovation® and Ovation Prime iliac technology, the Ovation iX iliac stent graft is engineered to promote patency even in hostile anatomy. Ovation iX stands for integrated exchange, and the iliac stent graft was developed to improve physician ease of use and expand patient applicability. The less invasive, low-profile (10-13F) integrated sheath is designed to minimize vessel trauma. With flared limbs up to 28mm diameter and limb lengths up to 160mm, the broader size matrix and even lower profiles enable treatment of a wider range of AAA anatomies.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
TRIV:US $5.42 USD -0.03

TRIV Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Boston Scientific Corp $17.57 USD -0.23
CR Bard Inc $171.30 USD -1.47
Endologix Inc $14.75 USD -0.08
Lombard Medical Inc $4.26 USD +0.12
St Jude Medical Inc $73.03 USD -0.60
View Industry Companies

Industry Analysis


Industry Average

Valuation TRIV Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 3.3x
Price/Book 4.3x
Price/Cash Flow NM Not Meaningful
TEV/Sales NM Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TRIVASCULAR TECHNOLOGIES INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at